Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 52 (2018): Issue 4 (December 2018)
Open Access
Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells
Tanja Mesti
Tanja Mesti
,
Nadia Bouchemal
Nadia Bouchemal
,
Claire Banissi
Claire Banissi
,
Mohamed N. Triba
Mohamed N. Triba
,
Carole Marbeuf-Gueye
Carole Marbeuf-Gueye
,
Maja Cemazar
Maja Cemazar
,
Laurence Le Moyec
Laurence Le Moyec
,
Antoine F. Carpentier
Antoine F. Carpentier
,
Philippe Savarin
Philippe Savarin
and
Janja Ocvirk
Janja Ocvirk
| Nov 26, 2018
Radiology and Oncology
Volume 52 (2018): Issue 4 (December 2018)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Nov 26, 2018
Page range:
392 - 398
Received:
Nov 30, 2017
Accepted:
Oct 21, 2018
DOI:
https://doi.org/10.2478/raon-2018-0046
© 2018 Tanja Mesti, Nadia Bouchemal, Claire Banissi, Mohamed N. Triba, Carole Marbeuf-Gueye, Maja Cemazar, Laurence Le Moyec, Antoine F. Carpentier,Philippe Savarin, Janja Ocvirk, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.